logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.

    • Cholinesterase Inhibitor class drugs

    FiltersReset Filters
    8 results

    • donepezil

      (Donepezil hydrochloride)
      Quallent Pharmaceuticals Health LLC
      Usage: Donepezil hydrochloride tablets are indicated for treating Alzheimer's disease dementia, with proven efficacy in patients across mild, moderate, and severe stages.

    • donepezil hydrochloride

      (donepezil hydrochloride)
      Unichem Pharmaceuticals (USA), Inc.

    • galantamine

      (galantamine)
      Slate Run Pharmaceuticals, LLC
      Usage: Galantamine tablets are indicated for the treatment of mild to moderate Alzheimer's-type dementia.

    • galantamine

      (galantamine)
      TWi Pharmaceuticals USA, Inc.
      Usage: Galantamine tablets are indicated for treating mild to moderate Alzheimer's-type dementia.

    • malathion

      (Malathion)
      Taro Pharmaceuticals U.S.A., Inc.
      Usage: Malathion lotion is indicated for the treatment of head lice (Pediculus humanus capitis) and their eggs (ova) on the scalp.

    • namzaric

      (memantine hydrochloride and donepezil hydrochloride)
      Allergan, Inc.
      Usage: NAMZARIC is indicated for treating moderate to severe Alzheimer's-type dementia in patients who are stabilized on a daily dose of 10 mg of donepezil hydrochloride.

    • neostigmine methylsulfate

      (NEOSTIGMINE METHYLSULFATE)
      ENDO USA, Inc.
      Usage: Neostigmine methylsulfate injection is a cholinesterase inhibitor used to reverse the effects of nondepolarizing neuromuscular blocking agents following surgery.

    • pyridostigmine bromide

      (Pyridostigmine bromide)
      Amneal Pharmaceuticals LLC
      Usage: Pyridostigmine bromide is indicated as pretreatment against soman nerve agent poisoning in adults, used in conjunction with protective garments. It should be discontinued at the first sign of poisoning, with immediate initiation of atropine and pralidoxime therapy. Effectiveness is based on animal studies.